Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy -

Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy

Herbert B. Newton (Herausgeber)

Buch | Hardcover
848 Seiten
2026 | 3rd edition
Academic Press Inc (Verlag)
978-0-443-27356-8 (ISBN)
CHF 349,95 inkl. MwSt
  • Noch nicht erschienen (ca. Februar 2026)
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Handbook of Brain Tumor Chemotherapy, Molecular Therapies, and Immunotherapy, Third Edition offers a unique cutting-edge collection of basic science and clinical information brain tumor chemotherapy research. The book represents the most complete single-volume resource available for information on the subject of brain tumor chemotherapy. Including a multidisciplinary approach, this volume combines recent advances tumor therapy with molecular biology, molecular therapeutics, immunobiology, and immunotherapy approaches in one location. Chapters new to this volume include cutting-edge research on the molecular underpinnings of brain tumors such as glioblastoma, other gliomas, and targeted molecular therapies to consider for treatment.

Herbert B. Newton, M.D., FAAN, is currently the Medical Director for the Neuro-Oncology Program and Brain Tumor Institute at the University Hospitals Cleveland Medical Center and Seidman Cancer Center, in Cleveland, Ohio, where he is also a Professor of Neurology and Solid Tumor Oncology, and holds the William Burton Risman Neurological Institute Chair in Memory and Cognition. Prior to that he was the Director of the Neuro-Oncology Center and Medical Neuro-Oncology Program at the Advent Health Cancer Institute and Advent Health Orlando Campus in Orlando, Florida. He is also retired as a Professor of Neurology and Neurosurgery, Dardinger Neuro-Oncology Center, Esther Dardinger Endowed Chair in Neuro-Oncology and Division of Neuro-Oncology at the Ohio State University Medical Center and James Cancer Hospital, in Columbus, Ohio. He is a Diplomate of the American Board of Psychiatry and Neurology, a Fellow of the American Academy of Neurology and Royal Society of Medicine, and a member of numerous national and international societies.

Section 1: PHARMACOLOGICAL AND CLINICAL APPLICATIONS
Section 2: INNOVATIVE CHEMOTHERAPY DELIVERY
Section 3: MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICS
Section 4: CHEMOTHERAPY SPECIFIC TUMORS – ADULTS
Section 5: CHEMOTHERAPY SPECIFIC TUMORS – PEDIATRICS
Section 6: IMMUNOTHERAPY FOR BRAIN TUMORS
Section 7: RESPONSE ASSESSMENT, QUALITY OF LIFE, NEUROPSYCHOLOGY, AND NEW FRONTIERS

Erscheint lt. Verlag 1.2.2026
Verlagsort San Diego
Sprache englisch
Maße 216 x 276 mm
Gewicht 450 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Naturwissenschaften Biologie Humanbiologie
Naturwissenschaften Biologie Zoologie
ISBN-10 0-443-27356-1 / 0443273561
ISBN-13 978-0-443-27356-8 / 9780443273568
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
interdisziplinäre Diagnose- und Behandlungsstrategien

von Christoph Maier; Ulrike Bingel; Esther Pogatzki-Zahn

Buch | Hardcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 135,75
Aus Klinik & Praxis

von Christian Henke; Johannes Rieger; Rebecca Seiler

Buch | Softcover (2025)
Urban & Fischer in Elsevier (Verlag)
CHF 54,60